WHERE TO WATCH
Gilead Misses in Q2 Earnings Report
July 30, 2020
Gilead reports a significant miss in earnings with revenue at $5.1 billion vs an expected $5.31 billion. The company says its misses are due to increased spending on coronavirus testing trials.
5 Rulings That Shaped Ruth Bader Ginsburg's Business Legacy
Sep 10, 2020
Breaking Down the Stages of Vaccine Test Trials
As pharmaceutical companies face mounting pressure to create an effective COVID-19 vaccine, we're taking a look at the time it takes to develop one, run it through several trials of testing, and come up with a final product. Cheddar's Azia Celestino and Kristen Scholer report.
Apr 24, 2020
Futures Point Higher Despite Reports of Disappointing Gilead Treatment Trial
Futures are higher this morning after stocks closed relatively flat on Thursday. Investors digesting a report that trials of Gilead Sciences' potential coronavirus treatment, remdesivir led to disappointing results, a sign of how important a coronavirus treatment is to Wall Street and markets around the world. We spoke to Frances Newton Stacy, Director of Strategy at Optimal Capital, for more on the markets.
Jul 30, 2020
Earnings Roundup: Facebook, Amazon, Google, Apple, and More
Here are some of the notable earnings reports from 2020 Q2.